Global Serialization (Supply Chain) Co-op
Eisai
Summary
Eisai is seeking an intern to join our team for a 6-month assignment. Working under the guidance of Global Serialization business, technical and project leads, the Co-Op will contribute to SOP maintenance, master data activities, issue coordination, and cross-functional collaboration across supply chain partners. The Co-Op will gain exposure to global serialization operations, market compliance requirements, business continuity planning, and process improvement initiatives that support a reliable and compliant serialized supply chain.
Job description
Essential Functions
- Support Global Serialization team members in day-to-day business operations that help maintain compliant product traceability across the global pharmaceutical supply chain.
- Assist with documentation updates, including SOPs, work instructions, and training materials related to serialization business processes and operational controls.
- Support master data maintenance activities across serialization, government, and third-party partner connections under guidance.
- Assist with preparation of business test scenarios and sample data to support process validation, partner onboarding, and operational readiness activities.
- Participate in basic issue intake, triage, and follow-up activities, ensuring items are routed appropriately to senior team members and partner functions.
- Support ongoing process improvement initiatives, documentation harmonization, and operational efficiency efforts across the Global Serialization organization.
- Observe and support onboarding, integration, and readiness activities for supply chain partners, markets, and serialized product flows.
- Participate in global team meetings and cross-functional collaboration to build understanding of serialization operations, compliance requirements, and supply chain business processes.
Requirements
- At least 18 years of age prior to scheduled start date
- Hybrid role requiring onsite presence Tuesday through Thursday
- Must be currently enrolled in a Bachelors degree program in Supply Chain Management, Operations, Business, Industrial Engineering, Logistics, or a related field
- Strong interest in pharmaceutical supply chain operations, serialization, product traceability, or regulatory compliance
- Proficiency with Microsoft O365 applications (Excel, Word, PowerPoint, Teams, OneNote, Outlook, CoPilot) for documentation, coordination, and analysis
- Ability to learn business processes, enterprise systems, and compliance concepts quickly
- Ability to use digital tools and emerging technologies, including AI, thoughtfully to improve efficiency, accuracy, and workflow effectiveness under guidance
- Awareness of responsible use of data, confidentiality, and appropriate practices when working within enterprise systems and regulated business processes
- Strong attention to detail and commitment to data accuracy, documentation quality, and operational compliance
- Structured, logical problem-solving skills to support data review, process coordination, and issue follow-up activities
- Demonstrated curiosity, willingness to learn, and ability to take direction and feedback constructively
- Effective written and verbal communication skills
- Ability to manage multiple tasks with appropriate prioritization under supervision
- Professional demeanor and ability to collaborate with global, cross-functional teams
- Interest in business operations, supply chain processes, and continuous improvement within a regulated environment
- Comfortable participating in virtual meetings and working in a hybrid environment
Company overview
Eisai Co., Ltd. is a leading Japanese pharmaceutical company headquartered in Tokyo, Japan, with a significant global presence through its U.S. subsidiary Eisai Inc. Founded in 1941, Eisai has grown to become a major player in the pharmaceutical industry with approximately 10,000 employees worldwide, including about 1,500 dedicated to research and development. The company operates as a fully integrated pharmaceutical business with strategic focus areas in neurology and oncology, particularly specializing in dementia-related diseases, neurodegenerative disorders, and cancer treatments. Eisai is publicly traded on the Tokyo Stock Exchange and is a constituent of both the TOPIX 100 and Nikkei 225 indices. The company is renowned for its innovative drug portfolio including Aricept (donepezil) for Alzheimer's disease, Lenvima (lenvatinib) for various cancers, and the recently approved Leqembi (lecanemab) for Alzheimer's treatment. Eisai's corporate philosophy centers on its 'human health care' (hhc) mission, which prioritizes patient needs and drives the company's research and development efforts across multiple global locations including Japan, the United States, United Kingdom, and other key markets.